The FDA has approved a re-engineered formulation of nilotinib with no mealtime restrictions for adult patients with newly ...
The FDA has approved Nerivio REN to include the acute and/or preventive treatment of migraine in patients 8 years of age and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback